CSP Advocacy Committee successfully testifies in Hartford to win a critical change to SB-4
"and (B) does not include any individual who (i) is licensed by this state to provide health care services, and (ii) while acting within the scope of such individual's practice, orders genetic testing for a medical purpose;”
Why does this single sentence in a 31 page omnibus consumer data privacy protection bill matter?
CSP's testimony ensured protection of CT pathologists and other physicians from burdensome regulatory requirements directed at direct-to-consumer genetic testing companies.
Who in CSP achieved this? Your CSP Advocacy Committee
CT legislature only allows a few days to review and respond to proposed legislation, the CSP Advocacy Committee in coordination with the College of American Pathologists, prepared written and oral testimony to the CT General Law Committee. In addition, the CSP Advocacy Committee reached out to the CT Hospital Association and CT State Medical Society to also submit written testimony in support of CSP's position to amend the raised bill.
In April 2026, the CT delegation to CAP's House of Delegates attended the annual CAP Pathology Leadership Summit. Although a small state and a recently re-established state society, the Connecticut delegation had a very strong showing at both the CAP HoD meeting and on Capitol Hill.